Literature DB >> 25052114

[Seroprevalence of Bartonella henselae and Bartonella quintana in blood donors in Aydin province, Turkey].

Neriman Aydin1, Rıfat Bülbül, Murat Tellı, Berna Gültekın.   

Abstract

Bartonella species cause several diseases in humans such as cat stratch disease, bacillary angiomatosis, peliosis hepatis, endocarditis, Carrion disease and trench fever. Cat scratch disease and bacillary angiomatosis cases have already been reported in Turkey. Studies from our region, namely Aydin (a province located at Western Anatolia, Turkey) indicated that mean Bartonella henselae IgG seropositivity rate is 11.5% in risk groups and may reach to 26.5% in pet owners. The aim of this study was to determine the seroprevalence of B.henselae and B.quintana in healthy blood donors in our university hospital in Aydin, for estimating the transmission risk via transfusion. The study was designed as a cross-sectional epidemiological study. A total of 333 samples taken from blood donors (49 female, 284 male) who were sequentially admitted to the blood center of the university hospital, in January 2011 were included in the study. All sera were screened in terms of B.henselae and Bartonella quintana IgG antibodies by using two different indirect immunofluorescent antibody (IFA) commercial kits (Vircell, Spain; Focus, USA). Slides were examined at a final magnification of x400 on fluorescent microscope by two different assigned researchers. Fluorescent intensity was graded between 1+ to 4+, and the samples with fluorescence value of ≥ 2+ were considered as positive. The seropositivity rate of IgG antibodies to B.henselae was found as 3.3% (11/333) in blood donors. This rate was 4.1% in female, and 3.2% in male donors, showing no statistically significant difference between the genders (p= 0.668). B.henselae antibody titers were detected as 1/64 in 6 (1.8%), 1/128 in 4 (1.2%) and 1/1024 in 1 (0.3%) patient. All of the B.henselae IgG positive samples also yielded relatively low positivity for B.quintana IgG, possibly indicating cross reactivity. The fluorescence intensity for different kits used was found to be the same in all but one titer. The results reported by two researchers were found to differ only in the samples graded 1+ or below. However, the evaluation differences between the kits and the researchers did not affect the results. It was concluded that B.henselae infection might be found in the blood donors in our region, thus, a detailed questionnaire prior to blood donation might be helpful to prevent transmission of B.henselae by blood transfusion.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25052114

Source DB:  PubMed          Journal:  Mikrobiyol Bul        ISSN: 0374-9096            Impact factor:   0.622


  4 in total

1.  The seroprevalence of Bartonella spp. in the blood of patients with musculoskeletal complaints and blood donors, Poland: a pilot study.

Authors:  Monika E Łysakowska; Olga Brzezińska; Małgorzata Szybka; Magdalena Konieczka; Sylwia Moskwa; Małgorzata Brauncajs; Joanna Makowska; Dorota Pastuszak-Lewandoska; Janina Grzegorczyk
Journal:  Clin Rheumatol       Date:  2019-05-22       Impact factor: 2.980

2.  Characterization of Bartonella taylorii Strains in Small Mammals of the Turkish Thrace.

Authors:  Ceylan Polat; Bekir Çelebi; Sercan Irmak; Ahmet Karataş; Faruk Çolak; Ferhat Matur; Mustafa Sözen; Ibrahim Mehmet Ali Öktem
Journal:  Ecohealth       Date:  2021-03-31       Impact factor: 3.184

3.  Molecular prevalence and genetic diversity of Bartonella spp. in stray cats of İzmir, Turkey.

Authors:  Ahmet Efe Köseoğlu; Hüseyin Can; Mervenur Güvendi; Muhammet Karakavuk; Pumla Manyatsi; Sedef Erkunt Alak; Aysu Değirmenci Döşkaya; Aytül Gül; Mert Döşkaya; Adnan Yüksel Gürüz; Cemal Ün
Journal:  Parasit Vectors       Date:  2022-08-29       Impact factor: 4.047

Review 4.  Cutaneous manifestations of bartonellosis.

Authors:  Karina de Almeida Lins; Marina Rovani Drummond; Paulo Eduardo Neves Ferreira Velho
Journal:  An Bras Dermatol       Date:  2019-10-02       Impact factor: 1.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.